Delay between pregnancy confirmation and sickle cell and [corrected] thalassaemia screening: a population-based cohort study
- PMID: 18318968
- PMCID: PMC2249790
- DOI: 10.3399/bjgp08X277267
Delay between pregnancy confirmation and sickle cell and [corrected] thalassaemia screening: a population-based cohort study
Erratum in
- Br J Gen Pract. 2008 Apr;58(549):284
Abstract
Background: Antenatal sickle cell and thalassaemia screening sometimes occurs too late to allow couples a choice regarding termination of affected fetuses. The target gestational age for offering the test in the UK is 10 weeks.
Aim: To describe the proportion of women screened before 70 days' (10 weeks') gestation and the delay between pregnancy confirmation in primary care and antenatal sickle cell and thalassaemia screening.
Design of study: Cohort study of reported pregnancies.
Setting: Twenty-five general practices in two UK inner-city primary care trusts offering universal screening.
Method: Anonymised data on all pregnancies reported to participating general practices was collected for a minimum of 6 months.
Results: There were 1441 eligible women intending to proceed with their pregnancies, whose carrier status was not known. The median (interquartile range [IQR]) gestational age at pregnancy confirmation was 7.6 weeks (6.0-10.7 weeks) and 74% presented before 10 weeks. The median gestational age at screening was 15.3 weeks (IQR = 12.6-18.0 weeks), with only 4.4% being screened before 10 weeks. The median delay between pregnancy confirmation and screening was 6.9 weeks (4.7-9.3 weeks) After allowing for practice level variation, there was no association between delay times and maternal age, parity, and ethnic group.
Conclusion: About 74% of women consulted for pregnancy before 10 weeks' gestation but fewer than 5% of women were screened before the target time of 10 weeks. Reducing the considerable delay between pregnancy confirmation in primary care and antenatal sickle cell and thalassaemia screening requires methods of organising and delivering antenatal care that facilitate earlier screening to be developed and evaluated.
Figures
Comment in
-
Community-based maternity care in 2008.Br J Gen Pract. 2008 Mar;58(548):149-51. doi: 10.3399/bjgp08X277249. Br J Gen Pract. 2008. PMID: 18318966 Free PMC article. No abstract available.
References
-
- Weatherall D, Akinyanju O, Fucharoen S, et al. Inherited disorders of hemoglobin. In: Jamieson DT, Mosely WH, Measschon AR, editors. Disease control priorities in developing countries. 2nd edn. Oxford: Oxford University Press and The World Bank; 1993. pp. 663–680.
-
- World Health Organisation. 59th World Health Assembly Agenda, Item 11.4; Geneva, Switzerland: WHO; 2006. www.who.int/gb/ebwha/pdf_files/WHA59/A59_R20-en.pdf (accessed 25 Jan 2008)
-
- NHS Sickle Cell and Thalassaemia Screening Programme. Standards for linked antenatal and newborn screening programme. London: UK National Screening Programme, King's College; 2006.
-
- National Institute for Clinical Excellence. Antenatal care: routine care for the healthy pregnant woman. London: RCOG press; 2003. Clinical Guideline 6. - PubMed
-
- Department of Health. National Service Framework for Children, young people and maternity services: maternity services. London: Department of Health; 2004. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials